IMAGION BIOSYSTEMS LIMITED

INVESTOR PRESENTATION - IMAGION BIOSYSTEMS LIMITED

ASX:IBX

IMAGION BIOSYSTEMS LIMITED

Health Care

Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.

Read more

Market Cap

74.28m

Price at Close

$0.085

4w avg. Volume

28.30m

4w avg. Turnover

$1.91m

Announcements
announcementt+2 movementdate
  • Response to ASX Price Query

    ASX Query · Market sensitive

  • -14.14%

    12 Aug 2020

-14.14%

12 Aug 2020
  • Change of Director's Interest Notice - Robert Proulx

    Shareholder Details

  • +2.60%

    11 Aug 2020

+2.60%

11 Aug 2020
  • Change of Director's Interest Notice - Michael Harsh

    Shareholder Details

  • +2.60%

    11 Aug 2020

+2.60%

11 Aug 2020
  • Change of Director's Interest Notice - Mark Van Asten

    Shareholder Details

  • +2.60%

    11 Aug 2020

+2.60%

11 Aug 2020
  • Change of Director's Interest Notice - Jovanka Naumoska

    Shareholder Details

  • +2.60%

    11 Aug 2020

+2.60%

11 Aug 2020
  • Change of Director's Interest Notice - Dianne Angus

    Shareholder Details

  • +2.60%

    11 Aug 2020

+2.60%

11 Aug 2020
  • Change of Director's Interest Notice - David Ludvigson

    Shareholder Details

  • +2.60%

    11 Aug 2020

+2.60%

11 Aug 2020
  • Appendix 3G - FY20 Directors Options

    Issued Capital

  • +15.52%

    06 Aug 2020

+15.52%

06 Aug 2020
  • Appendix 3G - FY20 Performance Rights & Performance Options

    Issued Capital

  • +15.52%

    06 Aug 2020

+15.52%

06 Aug 2020
  • Imagion Biosystems Phase I study update

    Progress Report

  • +16.00%

    04 Aug 2020

+16.00%

04 Aug 2020
Market Data

Current Price

$0.085

52WK HIGH

$0.1

52WK LOW

$0.01

1YR RETURN

+73.47%

1YR RETURN VS. SECTOR

+20.04%

90 DAY RETURN

+269.57%

ASX RANK

847

/2,032

SECTOR RANK

12

/28

SHARES OUTSTANDING

873.89m
ASX:IBX

IMAGION BIOSYSTEMS LIMITED

Health Care

Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.

Read more

Market Cap

74.28m

Price at Close

$0.085

4w avg. Volume

28.30m

4w avg. Turnover

$1.91m

ASX:IBX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Support

Ask Fresh

Archive
Contact Us

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

(03) 9028 2888

deals@freshequities.com

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.